Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJordi Bruix, Josep M. Llovet, D. Voliotis et al.|Journal of Hepatology|2012Cited by 821
The natural history of compensated cirrhosis due to hepatitis C virusAngelo Sangiovanni, Massimo Colombo, Gian Maria Prati et al.|Hepatology|2006Cited by 631
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆Angelo Sangiovanni, Massimo Colombo, E. Del Ninno et al.|Gastroenterology|2004Cited by 607
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV InfectionElisabetta Degasperi, Pietro Lampertico, Roberta D’Ambrosio et al.|Clinical Gastroenterology and Hepatology|2018Cited by 114
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVíctor Sapena, María Reig, Marco Enea et al.|Gut|2021Cited by 96